Case Study
How UCSF Is Building Confidence
in Outpatient Advanced Therapies
UCSF Health launched outpatient and hybrid pathways for CAR‑T, bispecific and autologous BMT patients, supported by Current Health’s passive monitoring and 24/7 nurse oversight.
THE OPPORTUNITY
Advanced therapy demand is outgrowing inpatient beds
CAR‑T and bispecific therapies have meant long, planned inpatient stays for post‑infusion and step-up dosing (SUD) monitoring — occupying valuable beds for days or weeks. UCSF wanted to expand access and protect margin without compromising safety or clinical oversight.
Bed bottleneck
High-value bed requirements for post-infusion monitoring limited the volume of advanced therapy cases that UCSF could accommodate.
Capped throughput
With volume limited by inpatient capacity, referral demand became a ceiling instead of an opportunity to grow.
Uncompromised oversight
Moving care home only works if the clinical team keeps continuous visibility and can escalate the moment it matters.
Eligible patients go home after infusion with a Current Health kit. Passive monitoring and a dedicated nurse team do the watching, catching deterioration early and escalating to the UCSF clinical team according to program protocols.